Serono Cetrotide
Executive Summary
Gonadotropin releasing hormone will be marketed, distributed and sold exclusively by Serono under a deal reached with Asta Medica. The two companies were scheduled to co-promote Cetrotide (cetrorelix) worldwide except for Japan. The NDA, approved Aug. 11, will now be transferred to Serono (1"The Pink Sheet" Aug. 21, p. 10)
You may also be interested in...
Asta Medica Cetrotide Approved For Single- And Multiple-Dose Regimens
Asta Medica's Cetrotide (cetrorelix) controlled ovarian stimulation injection received FDA approval for a 3 mg single-dose regimen and a .25 mg multiple-dose regimen on Aug. 11.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials